跳至主要内容
临床试验/NCT02111434
NCT02111434已完成4 期

Phase 4 Study of Effect of Testosteron Treatment on the Visceral Adiposity Index and Triglyceride/High-density Lipoprotein Cholesterol Ratio in the Congenital Hypogonadotropic Hypogonadism

Gulhane School of Medicine1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2013年7月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
150
试验地点
1
主要终点
time to change of visceral adiposity index with testosteron replacement

研究概览

简要总结

The study is designed to answer the following questions:

  1. What is the levels of visceral adiposity index and Triglycerides/HDL cholesterol ratio in hypogonadism?
  2. What is the effect of testosterone replacement on the visceral adiposity index and Triglycerides/HDL cholesterol ratio?

详细描述

This is a retrospective design, which is performed by investigating the registrations of patients with hypogonadotrophic hypogonadism between the years 2007-2010.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Screening
盲法
None

入排标准

年龄范围
18 Years 至 26 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • Congenital hypogonadism
  • Treatment Naive

排除标准

  • Previous history of androgen replacement
  • Hypertension
  • Diabetes mellitus

研究组 & 干预措施

testosterone

Experimental

testosterone gel per day for 6 months testosterone 250 mg injection per 3-4 weeks for 6 months

干预措施: Testosterone (Drug)

结局指标

主要结局

time to change of visceral adiposity index with testosteron replacement

时间窗: baseline and 6 months

time to change of TG/HDL cholesterol ratio with testosteron replacement

时间窗: baseline and 6 months

次要结局

未报告次要终点

研究者

发起方
Gulhane School of Medicine
申办方类型
Other
责任方
Principal Investigator
主要研究者

cem haymana

MD

Gulhane School of Medicine

研究点 (1)

Loading locations...

相似试验

Visceral Adiposity Index and... | 临床试验